WALTHAM, Mass., May 05, 2022 (GLOBE NEWSWIRE) —


Apellis Pharmaceuticals


, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will present at the Bank of America Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 8:40 a.m. PT .

The event will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s

website

. A replay of the webcast will be available for 30 days following the event.

About Apellis


Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit

www.apellis.com

.

Investor Contact:


Meredith Kaya


[email protected]


617.599.8178